GenInvo

GENINVO is a life sciences technology company dedicated to redefining the clinical study landscape through next-generation AI-powered solutions. The company empowers pharmaceutical and life sciences organizations to conduct smarter, faster, and more compliant clinical trials by delivering intelligent data solutions, automation tools, and enterprise-grade software. With a unique combination of expertise spanning life sciences, leading-edge technologies, and software development, GENINVO serves as a trusted go-to partner for the global life science industry.

All GENINVO products are designed to be scalable, secure, and customizable. The product portfolio includes plug-and-play modules and off-the-shelf licensing options, enabling hassle-free deployment within existing infrastructure. The company maintains offices in the US, India, UK, and Canada, and holds industry certifications including ISO 27001 compliance through its Information Security Management System (ISMS) implementation.

Product Portfolio

• Data and Document Anonymization Solution: A dedicated platform supporting global data sharing and transparency initiatives, including redaction and risk assessment capabilities.
• Next Generation Enterprise Platform: A scalable, enterprise-ready platform built to meet the evolving needs of life sciences organizations.
• Automation of Synthetic Data Generation: A solution that automates the creation of synthetic data to support clinical research and development workflows.
• Quality Checks Automation Tool for Medical Writers: A Generative AI-powered tool designed to automate document quality control processes for medical writing teams.
• Document Generation Software: Software that streamlines and automates the creation of clinical and regulatory documents.

Core Service Offerings

• Anonymization As a Service: Customized anonymization services supporting global data sharing, transparency initiatives, redaction, and risk assessment.
• Innovation As a Service: Development of tailor-made, scalable solutions designed for enterprise deployment and aligned to each client's specific needs.
• Custom Application Development: Expert teams deliver personalized tools and processes precisely tailored to customer requirements.
• Collaborative Innovation: GENINVO works directly with client stakeholders to develop efficient automation solutions that accurately fit each organization's unique challenges, recognizing that a one-size-fits-all approach is not sufficient for the pharma industry.
• Data Science Centre of Excellence (CoE): A dedicated center serving as the pillar for Artificial Intelligence and Machine Learning capabilities, supporting data visualization, custom software development, and other advanced analytics services.
• Cloud Managed Services: Managed cloud solutions designed to provide a clear path toward achieving desired business outcomes in today's dynamic environment.
• Talent Resource Hub: Access to life science subject matter experts and software and technology professionals supporting a wide range of solution areas.

Compliance, Security, and Industry Leadership

• ISO 27001 / ISMS Implementation: GENINVO establishes comprehensive Information Security Management System security controls covering all information assets of clients, employees, and business partners.
• Industry Certifications: The company holds recognized compliance certifications demonstrating its commitment to security and regulatory standards relevant to the life sciences sector.
• Enterprise Deployment Readiness: Products are built for plug-and-play integration with existing infrastructure, reducing deployment complexity for enterprise clients.

With a global presence and a strong foundation in AI, data science, and life sciences domain expertise, GENINVO positions itself as a comprehensive innovation partner for pharmaceutical and clinical research organizations seeking to modernize their operations and accelerate compliant, data-driven clinical development.